EE200200671A - Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks - Google Patents
Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseksInfo
- Publication number
- EE200200671A EE200200671A EEP200200671A EEP200200671A EE200200671A EE 200200671 A EE200200671 A EE 200200671A EE P200200671 A EEP200200671 A EE P200200671A EE P200200671 A EEP200200671 A EE P200200671A EE 200200671 A EE200200671 A EE 200200671A
- Authority
- EE
- Estonia
- Prior art keywords
- hygromycin
- bacterial
- derivatives
- treatment
- protozoal infections
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 206010037075 Protozoal infections Diseases 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical class O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20902300P | 2000-06-02 | 2000-06-02 | |
| PCT/IB2001/000946 WO2001092280A1 (en) | 2000-06-02 | 2001-05-25 | Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200671A true EE200200671A (et) | 2004-08-16 |
Family
ID=22777009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200671A EE200200671A (et) | 2000-06-02 | 2001-05-25 | Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6867230B2 (es) |
| EP (1) | EP1287011A1 (es) |
| JP (1) | JP2003535100A (es) |
| KR (1) | KR20030010655A (es) |
| CN (1) | CN1432019A (es) |
| AP (1) | AP2002002669A0 (es) |
| AR (1) | AR028667A1 (es) |
| AU (1) | AU2001260528A1 (es) |
| BG (1) | BG107265A (es) |
| BR (1) | BR0111242A (es) |
| CA (1) | CA2410643A1 (es) |
| CZ (1) | CZ20023859A3 (es) |
| EA (1) | EA200201167A1 (es) |
| EC (1) | ECSP014093A (es) |
| EE (1) | EE200200671A (es) |
| GT (1) | GT200100099A (es) |
| HU (1) | HUP0302263A2 (es) |
| IL (1) | IL152984A0 (es) |
| IS (1) | IS6618A (es) |
| MA (1) | MA26909A1 (es) |
| MX (1) | MXPA02011966A (es) |
| NO (1) | NO20025704L (es) |
| OA (1) | OA12277A (es) |
| PA (1) | PA8518101A1 (es) |
| PE (1) | PE20020334A1 (es) |
| PL (1) | PL359179A1 (es) |
| SK (1) | SK16612002A3 (es) |
| SV (1) | SV2002000474A (es) |
| TN (1) | TNSN01080A1 (es) |
| UY (1) | UY26741A1 (es) |
| WO (1) | WO2001092280A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4488350B2 (ja) * | 2002-05-16 | 2010-06-23 | セプラコール インク． | 哺乳類アナンダミド輸送体を阻害するアミン、およびその使用方法 |
| CA3110075A1 (en) | 2018-08-20 | 2020-02-27 | Northeastern University | Hygromycin a compounds and methods of treating spirochete diseases |
| CU20180159A7 (es) * | 2018-12-28 | 2020-10-20 | Chengdu Olisynn Biotechnology Co Ltd | Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1234567A (en) * | 1915-09-14 | 1917-07-24 | Edward J Quigley | Soft collar. |
| US2004123A (en) * | 1934-02-15 | 1935-06-11 | Jr Robert B Loibl | Pest exterminator |
| HUP0102412A3 (en) * | 1998-05-04 | 2003-07-28 | Pfizer Prod Inc | 2"-deoxy hygromycin derivatives |
| HRP20000747A2 (en) * | 1998-05-04 | 2001-06-30 | Pfizer Prod Inc | Hygromycin a derivatives |
| OA11721A (en) * | 1998-12-02 | 2005-01-25 | Pfizer Prod Inc | Hygromycin A derivatives as antibacterial agents. |
| HK1049672A1 (zh) * | 1999-10-29 | 2003-05-23 | 辉瑞产品公司 | 潮霉素衍生物 |
| US7654321B2 (en) * | 2006-12-27 | 2010-02-02 | Schlumberger Technology Corporation | Formation fluid sampling apparatus and methods |
-
2001
- 2001-05-25 EA EA200201167A patent/EA200201167A1/ru unknown
- 2001-05-25 EP EP01934231A patent/EP1287011A1/en not_active Withdrawn
- 2001-05-25 AU AU2001260528A patent/AU2001260528A1/en not_active Abandoned
- 2001-05-25 AP APAP/P/2002/002669A patent/AP2002002669A0/en unknown
- 2001-05-25 PL PL01359179A patent/PL359179A1/xx not_active Application Discontinuation
- 2001-05-25 CZ CZ20023859A patent/CZ20023859A3/cs unknown
- 2001-05-25 KR KR1020027016396A patent/KR20030010655A/ko not_active Ceased
- 2001-05-25 BR BR0111242-2A patent/BR0111242A/pt not_active IP Right Cessation
- 2001-05-25 MX MXPA02011966A patent/MXPA02011966A/es not_active Application Discontinuation
- 2001-05-25 CN CN01810623A patent/CN1432019A/zh active Pending
- 2001-05-25 JP JP2002500893A patent/JP2003535100A/ja not_active Withdrawn
- 2001-05-25 EE EEP200200671A patent/EE200200671A/xx unknown
- 2001-05-25 CA CA002410643A patent/CA2410643A1/en not_active Abandoned
- 2001-05-25 SK SK1661-2002A patent/SK16612002A3/sk unknown
- 2001-05-25 IL IL15298401A patent/IL152984A0/xx unknown
- 2001-05-25 OA OA1200200361A patent/OA12277A/en unknown
- 2001-05-25 HU HU0302263A patent/HUP0302263A2/hu unknown
- 2001-05-25 WO PCT/IB2001/000946 patent/WO2001092280A1/en not_active Ceased
- 2001-05-30 PA PA20018518101A patent/PA8518101A1/es unknown
- 2001-05-30 GT GT200100099A patent/GT200100099A/es unknown
- 2001-05-31 UY UY26741A patent/UY26741A1/es not_active Application Discontinuation
- 2001-06-01 SV SV2001000474A patent/SV2002000474A/es not_active Application Discontinuation
- 2001-06-01 TN TNTNSN01080A patent/TNSN01080A1/fr unknown
- 2001-06-01 AR ARP010102642A patent/AR028667A1/es unknown
- 2001-06-01 PE PE2001000511A patent/PE20020334A1/es not_active Application Discontinuation
- 2001-06-01 US US09/872,731 patent/US6867230B2/en not_active Expired - Fee Related
- 2001-06-01 EC EC2001004093A patent/ECSP014093A/es unknown
-
2002
- 2002-11-12 BG BG107265A patent/BG107265A/bg unknown
- 2002-11-14 IS IS6618A patent/IS6618A/is unknown
- 2002-11-27 NO NO20025704A patent/NO20025704L/no not_active Application Discontinuation
- 2002-11-29 MA MA26928A patent/MA26909A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030010655A (ko) | 2003-02-05 |
| AU2001260528A1 (en) | 2001-12-11 |
| AP2002002669A0 (en) | 2002-12-31 |
| EP1287011A1 (en) | 2003-03-05 |
| NO20025704D0 (no) | 2002-11-27 |
| EA200201167A1 (ru) | 2003-06-26 |
| MA26909A1 (fr) | 2004-12-20 |
| UY26741A1 (es) | 2001-12-28 |
| PE20020334A1 (es) | 2002-04-30 |
| CN1432019A (zh) | 2003-07-23 |
| WO2001092280A1 (en) | 2001-12-06 |
| TNSN01080A1 (fr) | 2005-11-10 |
| US20030045528A1 (en) | 2003-03-06 |
| MXPA02011966A (es) | 2003-04-22 |
| CA2410643A1 (en) | 2001-12-06 |
| NO20025704L (no) | 2002-11-27 |
| GT200100099A (es) | 2002-01-31 |
| IS6618A (is) | 2002-11-14 |
| US6867230B2 (en) | 2005-03-15 |
| PL359179A1 (en) | 2004-08-23 |
| BG107265A (bg) | 2003-07-31 |
| PA8518101A1 (es) | 2002-09-17 |
| IL152984A0 (en) | 2003-06-24 |
| BR0111242A (pt) | 2003-06-03 |
| JP2003535100A (ja) | 2003-11-25 |
| SK16612002A3 (sk) | 2004-04-06 |
| SV2002000474A (es) | 2002-07-03 |
| CZ20023859A3 (cs) | 2004-02-18 |
| ECSP014093A (es) | 2002-01-25 |
| AR028667A1 (es) | 2003-05-21 |
| OA12277A (en) | 2006-05-11 |
| HUP0302263A2 (hu) | 2003-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
| DE60029883D1 (de) | Medizinischer Vernebler | |
| PL376454A1 (en) | 1-acyl-pyrrolidine derivatives for the treatment of viral infections | |
| EE200300497A (et) | Pürasoolderivaadid HIV raviks | |
| NO20005839D0 (no) | Preparater for behandling av HIV og andre virale infeksjoner | |
| NO20015464D0 (no) | Attenuerte mikroorganismer for behandling av infeksjon | |
| AU2001269704A1 (en) | Oxazinoquinolones useful for the treatment of viral infections | |
| AU2281601A (en) | Treatment of viral infections using levovirinTM | |
| NO20043445L (no) | Kombinasjonsterapi for behandling av bakterielle infeksjoner | |
| PT1220858E (pt) | Oxazinoquinolonas uteis para o tratamento de infeccoes virais | |
| EE200200671A (et) | Hügromütsiin A derivaadid bakteriaalsete ja algloomadest põhjustatud infektsioonide ravimiseks | |
| NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| NO20032769D0 (no) | Kombinasjonsmetode for behandling av virale infeksjoner | |
| AP2002002432A0 (en) | Treatment of viral infections | |
| NO20013651D0 (no) | Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner | |
| AU2003301012A1 (en) | Use of beta-defensins for treating hiv infections | |
| AU4145999A (en) | Topical drug for the treatment of viral infections | |
| NO20022949D0 (no) | Attenuerte mikroorganismer for behandling av infeksjon | |
| NO20012540D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| IL143795A0 (en) | Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections | |
| AU2002251202A1 (en) | Intimins for the prevention or treatment of infections: i | |
| AU2001281465A1 (en) | Treatment of rosacea | |
| AU3524700A (en) | Prevention and treatment of viral infections | |
| AU2002360523A1 (en) | Compounds to treat hiv infection and aids | |
| AU1392601A (en) | Prevention and treatment of biomaterial-associated infections |